DOI: 10.1016/j.brainres.2004.10.030. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease

Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease

10.1016/j.brainres.2004.10.030

Crossref journal-article

Elsevier BV

Brain Research (78)

Bibliography

Reynolds, N. C., Prost, R. W., & Mark, L. P. (2005). Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntingtonâs disease. Brain Research, 1031(1), 82â89.

Authors 3

Norman C. Reynolds (first)
Robert W. Prost (additional)
Leighton P. Mark (additional)

References 28 Referenced 63

10.1001/archneur.1996.00550120105023 / Arch. Neurol. / Basal ganglia volume and proximity to onset in presymptomatic Huntington's disease by Aylward (1996)
10.1006/exnr.1993.1053 / Exp. Neurol. / Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural deterioration by Bazzett (1993)
10.1523/JNEUROSCI.13-10-04181.1993 / J. Neurosci. / Neurochemical and histology characterization of striatal excitotoxic lesions produced by the toxin 3-nitropropionic acid by Beal (1993)
10.1523/JNEUROSCI.20-12-04389.2000 / J. Neurosci. / Neuroprotective effects of creatine in transgenic mouse model of Huntington's disease by Ferrante (2000)
10.1002/ana.410310113 / Ann. Neurol. / Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease by Harris (1992)
10.1586/14737175.1.1.111 / Expert Rev. Neurotherapeutics / Neuroprotective therapy for Huntington's disease: new prospects and challenges by Hersch (2001)
10.1212/WNL.44.8.1369 / Neurology / The neurogenetics genie: testing for the Huntington's disease mutation by Hersch (1994)
10.1212/WNL.50.4.1033 / Neurology / Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's disease by Hoang (1998)
10.1002/mrm.1910330502 / MRM / Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study by Holshouser (1995)
10.1016/0092-8674(93)90585-E / Cell / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes (1993)
10.1212/WNL.57.3.397 / Neurology / A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington's disease (2001)
10.1212/01.WNL.0000133403.30559.FF / Neurology / Minocycline safety and tolerability in Huntington disease (2004)
10.1212/WNL.50.5.1357 / Neurology / 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers by Jenkins (1998)
10.1002/mds.870110310 / Mov. Disord. / A controlled trial of remacemide hydrochloride in Huntington's disease by Kieburtz (1996)
{'key': '10.1016/j.brainres.2004.10.030_bib15', 'first-page': 'A334', 'article-title': "Ubiquinone lowers occipital lactate levels in patients with Huntington's disease", 'volume': '43', 'author': 'Koroshetz', 'year': '1993', 'journal-title': 'Neurology'} / Neurology / Ubiquinone lowers occipital lactate levels in patients with Huntington's disease by Koroshetz (1993)
10.1212/WNL.53.5.1000 / Neurology / Influence of lamotrigine on progression of early Huntington's disease by Kremer (1999)
10.1212/WNL.34.8.1059 / Neurology / Huntington's disease: new approaches to an old problem by Martin (1984)
10.1016/S0165-0173(98)00012-5 / Brain Res. Rev. / Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders by Qian (1998)
{'issue': 'S5', 'key': '10.1016/j.brainres.2004.10.030_bib19', 'first-page': 'S320', 'article-title': "Identification of spermine in spectroscopic profiles of the putamen in presymptomatic Huntington's disease with magnetic resonance scanning at 0.5 Tesla", 'volume': '17', 'author': 'Reynolds', 'year': '2002', 'journal-title': 'Mov. Disord.'} / Mov. Disord. / Identification of spermine in spectroscopic profiles of the putamen in presymptomatic Huntington's disease with magnetic resonance scanning at 0.5 Tesla by Reynolds (2002)
10.1002/1531-8257(199903)14:2<326::AID-MDS1019>3.0.CO;2-Q / Mov. Disord. / Riluzole therapy in Huntington's disease by Rosas (1999)
10.1212/WNL.57.6.1025 / Neurology / Striatal volume loss in HD as measured by MRI and the influence of CAG repeats by Rosas (2001)
10.1212/WNL.53.4.806 / Neurology / Clinical correlation of striatal 1H MRS changes in Huntington's disease by Sanchez-Pernaute (1999)
10.1046/j.1471-4159.2000.0740060.x / J. Neurochem. / Spermine-induced toxicity in cerebellar granule neurons is independent of its actions at NMDA receptors by Segal (2000)
10.1002/mds.870110209 / Mov. Disord. / Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory by Taylor-Robinson (1997)
10.1212/WNL.56.5.592 / Neurology / Magnetic resonance spectroscopy in AD by Valenzuela (2001)
10.1212/WNL.59.5.694 / Neurology / Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine by Verhagen (2002)
10.1007/BF02033352 / J. Neurol. / What might be the impact on neurology of the analysis of brain metabolism by in vivo resonance spectroscopy? by Vion-Drury (1994)
10.1006/mcpr.1993.1034 / Mol. Cell. Probes / A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes by Warner (1993)

Dates

Type	When
Created	20 years, 8 months ago (Dec. 16, 2004, 11:51 a.m.)
Deposited	6 years, 7 months ago (Jan. 30, 2019, 11:20 p.m.)
Indexed	1 month, 4 weeks ago (July 1, 2025, 3:54 p.m.)
Issued	20 years, 7 months ago (Jan. 1, 2005)
Published	20 years, 7 months ago (Jan. 1, 2005)
Published Print	20 years, 7 months ago (Jan. 1, 2005)

Funders 0

None

BibTeX

@article{Reynolds_2005, title={Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington’s disease}, volume={1031}, ISSN={0006-8993}, url={http://dx.doi.org/10.1016/j.brainres.2004.10.030}, DOI={10.1016/j.brainres.2004.10.030}, number={1}, journal={Brain Research}, publisher={Elsevier BV}, author={Reynolds, Norman C. and Prost, Robert W. and Mark, Leighton P.}, year={2005}, month=jan, pages={82–89} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        1
      ]
    ],
    "date-time": "2025-07-01T19:54:37Z",
    "timestamp": 1751399677272
  },
  "reference-count": 28,
  "publisher": "Elsevier BV",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2005,
            1,
            1
          ]
        ],
        "date-time": "2005-01-01T00:00:00Z",
        "timestamp": 1104537600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        1
      ]
    ]
  },
  "DOI": "10.1016/j.brainres.2004.10.030",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        12,
        16
      ]
    ],
    "date-time": "2004-12-16T16:51:02Z",
    "timestamp": 1103215862000
  },
  "page": "82-89",
  "source": "Crossref",
  "is-referenced-by-count": 63,
  "title": "Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease",
  "prefix": "10.1016",
  "volume": "1031",
  "author": [
    {
      "suffix": "Jr.",
      "given": "Norman C.",
      "family": "Reynolds",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Robert W.",
      "family": "Prost",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Leighton P.",
      "family": "Mark",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.brainres.2004.10.030_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "1293",
      "DOI": "10.1001/archneur.1996.00550120105023",
      "article-title": "Basal ganglia volume and proximity to onset in presymptomatic Huntington's disease",
      "volume": "53",
      "author": "Aylward",
      "year": "1996",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1006/exnr.1993.1053",
      "article-title": "Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural deterioration",
      "volume": "120",
      "author": "Bazzett",
      "year": "1993",
      "journal-title": "Exp. Neurol."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "4181",
      "DOI": "10.1523/JNEUROSCI.13-10-04181.1993",
      "article-title": "Neurochemical and histology characterization of striatal excitotoxic lesions produced by the toxin 3-nitropropionic acid",
      "volume": "13",
      "author": "Beal",
      "year": "1993",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "4389",
      "DOI": "10.1523/JNEUROSCI.20-12-04389.2000",
      "article-title": "Neuroprotective effects of creatine in transgenic mouse model of Huntington's disease",
      "volume": "20",
      "author": "Ferrante",
      "year": "2000",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "DOI": "10.1002/ana.410310113",
      "article-title": "Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease",
      "volume": "3",
      "author": "Harris",
      "year": "1992",
      "journal-title": "Ann. Neurol."
    },
    {
      "issue": "1",
      "key": "10.1016/j.brainres.2004.10.030_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "DOI": "10.1586/14737175.1.1.111",
      "article-title": "Neuroprotective therapy for Huntington's disease: new prospects and challenges",
      "volume": "1",
      "author": "Hersch",
      "year": "2001",
      "journal-title": "Expert Rev. Neurotherapeutics"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "1369",
      "DOI": "10.1212/WNL.44.8.1369",
      "article-title": "The neurogenetics genie: testing for the Huntington's disease mutation",
      "volume": "44",
      "author": "Hersch",
      "year": "1994",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "1033",
      "DOI": "10.1212/WNL.50.4.1033",
      "article-title": "Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's disease",
      "volume": "50",
      "author": "Hoang",
      "year": "1998",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "589",
      "DOI": "10.1002/mrm.1910330502",
      "article-title": "Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study",
      "volume": "33",
      "author": "Holshouser",
      "year": "1995",
      "journal-title": "MRM"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "971",
      "DOI": "10.1016/0092-8674(93)90585-E",
      "article-title": "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes",
      "volume": "72",
      "year": "1993",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "DOI": "10.1212/WNL.57.3.397",
      "article-title": "A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington's disease",
      "volume": "57",
      "year": "2001",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "DOI": "10.1212/01.WNL.0000133403.30559.FF",
      "article-title": "Minocycline safety and tolerability in Huntington disease",
      "volume": "63",
      "year": "2004",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "1357",
      "DOI": "10.1212/WNL.50.5.1357",
      "article-title": "1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers",
      "volume": "50",
      "author": "Jenkins",
      "year": "1998",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "DOI": "10.1002/mds.870110310",
      "article-title": "A controlled trial of remacemide hydrochloride in Huntington's disease",
      "volume": "11",
      "author": "Kieburtz",
      "year": "1996",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib15",
      "first-page": "A334",
      "article-title": "Ubiquinone lowers occipital lactate levels in patients with Huntington's disease",
      "volume": "43",
      "author": "Koroshetz",
      "year": "1993",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "1000",
      "DOI": "10.1212/WNL.53.5.1000",
      "article-title": "Influence of lamotrigine on progression of early Huntington's disease",
      "volume": "5e",
      "author": "Kremer",
      "year": "1999",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "1059",
      "DOI": "10.1212/WNL.34.8.1059",
      "article-title": "Huntington's disease: new approaches to an old problem",
      "volume": "34",
      "author": "Martin",
      "year": "1984",
      "journal-title": "Neurology"
    },
    {
      "issue": "3",
      "key": "10.1016/j.brainres.2004.10.030_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "DOI": "10.1016/S0165-0173(98)00012-5",
      "article-title": "Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders",
      "volume": "27",
      "author": "Qian",
      "year": "1998",
      "journal-title": "Brain Res. Rev."
    },
    {
      "issue": "S5",
      "key": "10.1016/j.brainres.2004.10.030_bib19",
      "first-page": "S320",
      "article-title": "Identification of spermine in spectroscopic profiles of the putamen in presymptomatic Huntington's disease with magnetic resonance scanning at 0.5 Tesla",
      "volume": "17",
      "author": "Reynolds",
      "year": "2002",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "326",
      "DOI": "10.1002/1531-8257(199903)14:2<326::AID-MDS1019>3.0.CO;2-Q",
      "article-title": "Riluzole therapy in Huntington's disease",
      "volume": "14",
      "author": "Rosas",
      "year": "1999",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "1025",
      "DOI": "10.1212/WNL.57.6.1025",
      "article-title": "Striatal volume loss in HD as measured by MRI and the influence of CAG repeats",
      "volume": "57",
      "author": "Rosas",
      "year": "2001",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "806",
      "DOI": "10.1212/WNL.53.4.806",
      "article-title": "Clinical correlation of striatal 1H MRS changes in Huntington's disease",
      "volume": "53",
      "author": "Sanchez-Pernaute",
      "year": "1999",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "60",
      "DOI": "10.1046/j.1471-4159.2000.0740060.x",
      "article-title": "Spermine-induced toxicity in cerebellar granule neurons is independent of its actions at NMDA receptors",
      "volume": "74",
      "author": "Segal",
      "year": "2000",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "DOI": "10.1002/mds.870110209",
      "article-title": "Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory",
      "volume": "11",
      "author": "Taylor-Robinson",
      "year": "1997",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "592",
      "DOI": "10.1212/WNL.56.5.592",
      "article-title": "Magnetic resonance spectroscopy in AD",
      "volume": "56",
      "author": "Valenzuela",
      "year": "2001",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "694",
      "DOI": "10.1212/WNL.59.5.694",
      "article-title": "Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine",
      "volume": "59",
      "author": "Verhagen",
      "year": "2002",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "354",
      "DOI": "10.1007/BF02033352",
      "article-title": "What might be the impact on neurology of the analysis of brain metabolism by in vivo resonance spectroscopy?",
      "volume": "241",
      "author": "Vion-Drury",
      "year": "1994",
      "journal-title": "J. Neurol."
    },
    {
      "key": "10.1016/j.brainres.2004.10.030_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "DOI": "10.1006/mcpr.1993.1034",
      "article-title": "A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes",
      "volume": "7",
      "author": "Warner",
      "year": "1993",
      "journal-title": "Mol. Cell. Probes"
    }
  ],
  "container-title": "Brain Research",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0006899304017573?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0006899304017573?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        1,
        31
      ]
    ],
    "date-time": "2019-01-31T04:20:32Z",
    "timestamp": 1548908432000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0006899304017573"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005,
        1
      ]
    ]
  },
  "references-count": 28,
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2005,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "S0006899304017573"
  ],
  "URL": "http://dx.doi.org/10.1016/j.brainres.2004.10.030",
  "relation": {},
  "ISSN": [
    "0006-8993"
  ],
  "subject": [],
  "container-title-short": "Brain Research",
  "published": {
    "date-parts": [
      [
        2005,
        1
      ]
    ]
  }
}